Other Resources

• About Us
• Presentations
• Events

TCT 2008

Boston Scientific is proud to play a major role in TCT 2008 in Washington, D.C. From our significant floor presence inside the Washington Convention Center to our Oct. 14 symposium on the data and complex anatomies behind the SYNTAX™ Trial, we are honored to be able to provide you with valuable information and insight. Please visit us at Booth 814 on Level 2 to learn more about our expanding portfolio of cardiovascular stents, including the new TAXUS® Express® Atom™ Stent approved for small vessels.

 

SYNTAX Sessions of Note at TCT 2008:

Tuesday, October 14, 2008

Left Main* Primary Endpoint Results
Presented by Professor Patrick W. Serruys, MD, PhD
11:10-11:20 a.m.
Main Arena

3-Vessel Disease** Primary Endpoints
Presented by Professor Friedrich W. Mohr, MD, PhD
11:20-11:30 a.m.
Main Arena

A Further Focus on the SYNTAX Trial
Trial Design, Methodology, and Subgroup Analyses
2:00 - 6:00 p.m.
Washington Convention Center, Room 147AB
Presented by: Didier Carrie, MD | Kevin J. Beatt, MD, PhD | Antonio Colombo, MD | Ted E. Feldman, MD | A. Peter Kappetein, MD, PhD | David R. Holmes, MD | Michael J. Mack, MD | Professor Friedrich W. Mohr, MD, PhD | Marie-Claude Morice, MD, FACC, FES | Elisabeth Ståhle, MD | Professor Patrick W. Serruys, MD, PhD | Keith Dawkins, MD

Please Join Us:
The SYNTAX Trial: Understanding the Data in Complex Anatomies and Advanced Disease

Tuesday, October 14, 2008

Reception: 7:00 - 8:00 pm
Program: 8:00 - 10:00 pm
Renaissance Washington, Grand Ballroom
Moderator: Professor Patrick W. Serruys, MD, PhD, Thoraxcenter - Erasmus University, Rotterdam, Netherlands

* Isolated or in conjunction with 1, 2, 3, VD.
** Revascularization for all 3 vascular territories.

The safety and effectiveness of the TAXUS® Express® Stent have not been established in patients with lesions located in an unprotected left main or patients with multi-vessel disease or in lesions requiring more than one stent or multiple overlapping stents.